que pensez-vous de cette société?
cela ferait un beau partenaire, non?
Aerie Pharmaceuticals is a privately held, clinical-stage biotechnology company dedicated to the discovery and development of novel treatments for glaucoma. All technology of the company is based on internal discovery R&D and is protected by a strong IP portfolio.
The US-based company is located in Bridgewater, NJ and in Research Triangle Park, NC. Investors in Aerie are TPG Biotech, Alta Partners, Clarus Ventures, Sofinnova Ventures and Osage University Partners. In February 2011, the company closed a Series B financing of $30 million
The company has raised $61 million from current investors: Alta Partners, Clarus Ventures, Osage University Partners, Sofinnova Ventures, and TPG Biotech